期刊
DISCOVER ONCOLOGY
卷 13, 期 1, 页码 -出版社
SPRINGER
DOI: 10.1007/s12672-022-00493-2
关键词
Metastasis; Lung adenocarcinoma; Prognosis; Biomarker; 5
资金
- National Natural Science Foundation of China [82102901]
- Natural Science Foundation of Guangdong Province, China [2020KZDZX1160]
- Autonomous Foundation of the State Key Laboratory of Respiratory Diseases [SKLRD-QN-201907, SKLRD2016ZJ017]
- Opening Foundation of the State Key Laboratory of Respiratory Diseases [SKLRD-OP-201915]
This study found that RP11-10A14.5 is closely associated with clinical stage and prognosis of lung cancer, and may serve as a diagnostic and prognostic predictor for LUAD. Experimental results show that RP11-10A14.5 can promote the growth, invasion, and metastasis of lung cancer cells, and enhance the survival ability of metastatic cells by affecting cell adhesion and apoptosis.
Lung cancer is the malignancy most commonly seen worldwide. Emerging evidences indicated that lncRNAs may serve as a prognosis marker and play important role in NSCLC tumor biology. In this work, we analyzed the prognosis value of RP11-10A14.5 using TCGA and GEPIA database and expression profiles using PCR and FISH assay. The biological roles of RP11-10A14.5 in cell growth and invasion were determined by in vitro and in vivo experiments. Expression of RP11-10A14.5 is correlated with increased clinical stage and poor survival prognosis. In vitro experiments revealed that RP11-10A14.5 was widely expressed in lung cancer cell lines and mainly distributed in the cytoplasm and enhanced the growth, invasion and migration ability of NSCLC cell lines. Immunofluorescence assay suggested that RP11-10A14.5 may promote EMT by downregulating E-cadherin and upregulating N-cadherin and Vimentin. Flow cytometry results suggested that RP11-10A14.5 did not significantly affect cell cycle function, but could significantly inhibit apoptosis which may further enhance metastasis cell survival. In conclusion, RP11-10A14.5 is associated with clinical stage and poor survival outcome, may serve as a diagnosis and prognosis predictor for LUAD. Further, RP11-10A14.5 could promote LUAD cell growth and metastasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据